System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Valentin Derangère is an expert in Oncology at Centre Georges François Leclerc (France). Valentin Derangère has authored 129 publications, the most recent in 2026. SLR score: 396 (community average: 125). How the SLR is computed.

LeadR Profile

Valentin Derangère Centre Georges François Leclerc France
396 ScienceLeadR Reputation 396

Unlock

Register Login
Network Map

Oncology

Subspecialties: Immunology - Biochemistry - Gynecology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026
Source: PubMed

Centre Georges François Leclerc

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 129

Citations

Citations: 5 180 1st author: 13 Last author: 2 Unique author: 0

Main journals

Morphologie 11
Ann Oncol 8
Cancer Res 7
Oncoimmunology 7
J Clin Oncol 5

Best Journals

Ann Oncol 5
J Clin Oncol 2
Cancer Cell 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Understanding Venous Remodeling After Minimally Invasive and Noninvasive Treatments for Varicose Veins: A Mechanistic Narrative Review.
PMID 42930610 — immunohistochemistry, fibrosis, adhesives, therapeutics, tissues, varicose veins, veins		Med Sci (Basel)20260
Age-related distribution of homologous recombination deficiency in advanced ovarian carcinoma: a large real-world French cohort.
PMID 42462286 — cells, research design, recombination, genetic, homologous recombination, ovary, neoplasms, aged, recombinational dna repair, ovarian neoplasms, prevalence, therapeutics		Int J Gynecol Cancer20260
Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.
PMID 42151126 — cells, lymphocytes, macrophages, neoplasms, phenotype, immunity, colorectal neoplasms, cell death		Cell Death Dis20260
Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts.
PMID 42100890 — neoplasms, colon, biomarkers, deep learning, therapeutics, learning, prognosis, colonic neoplasms		Oncoimmunology20260
Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].
PMID 41946180 — neoplasms, colon, prognosis, colonic neoplasms		Eur J Cancer20260

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS